| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Mus musculus
|
Babett Steglich
|
|||||||
| GSM2358559 |
IL10RA wildtype
|
RNA |
|
1 | Babett Steglich | Dec 30, 2016 | |||
| GSM2358560 |
IL0RA-Impaired
|
RNA |
|
1 | Babett Steglich | Dec 30, 2016 | |||
| GSM3430880 |
IL-10+ CD4+ T-cells spleen
|
SRA |
|
1 | Babett Steglich | Nov 07, 2018 | |||
| GSM3430881 |
IL-10+ CD4+ T-cells small intestine
|
SRA |
|
1 | Babett Steglich | Nov 07, 2018 | |||
| GSM5257093 |
Myeloid cells from malignant pleural effusion_1
|
SRA |
|
1 | Babett Steglich | Aug 24, 2021 | |||
| GSM5257094 |
Myeloid cells from malignant pleural effusion_2
|
SRA |
|
1 | Babett Steglich | Aug 24, 2021 | |||
| GSM6706775 |
CD45+ IL-22- cells before intrasplenic cancer cell injection
|
SRA |
|
1 | Babett Steglich | Jan 10, 2023 | |||
| GSM6706776 |
CD45+ IL-22- cells 12h after intrasplenic cancer cell injection
|
SRA |
|
1 | Babett Steglich | Jan 10, 2023 | |||
| GSM6706777 |
CD45+ IL-22+ cells before intrasplenic cancer cell injection
|
SRA |
|
1 | Babett Steglich | Jan 10, 2023 | |||
| GSM6706778 |
CD45+ IL-22+ cells 12h after intrasplenic cancer cell injection
|
SRA |
|
1 | Babett Steglich | Jan 10, 2023 | |||
| GSM2442821 |
Wt IR #1
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442822 |
Wt IR #2
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442823 |
Wt IR #3
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442824 |
Il22-/- IR #1
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442825 |
Il22-/- IR #2
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442826 |
Il22-/- IR #3
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442827 |
Il22bp-/- IR #1
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442828 |
Il22bp-/- IR #2
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442829 |
Il22bp-/- IR #3
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 | |||
| GSM2442830 |
Wt sham #1
|
SRA |
|
1 | Babett Steglich | Dec 22, 2017 |
